Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase 2b trial, putting it in hot pursuit of Merck & Co's gefapixant, which was filed for approval in March.

At Senate HELP committee, lawmakers grill Robert F. Kennedy Jr. on his record of vaccine skepticism and thoughts on ...

Kennedy Jr., President Trump's pick for health secretary, has falsely linked vaccines to autism and argued people should have ...

A Post examination of Robert F. Kennedy Jr.’s statements finds the candidate for the nation’s top health post has repeatedly ...

The Illinois Department of Public Health (IDPH) announced that in line with the national trend, the state’s overall respiratory illness level has ticked up from Moderate to High, driven by ...

Cover your cough when you sneeze and use a tissue and not your hands ... including individuals over 65, individuals with chronic medical conditions and individuals who are immunocompromised.” The IDPH ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is meant to prevent cervical cancer that can be caused by the human ...

Kennedy Jr.'s secretary of the Department of Health and Human Services (HHS) confirmation hearing and how pharma stocks like Pfizer (PFE) and Merck (MRK) may be impacted: "There's been a lot of ...

Cough is a crucial protective reflex that helps protect the lungs and airways. However, when cough becomes chronic and ...